Logo image of INGN

INOGEN INC (INGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:INGN - US45780L1044 - Common Stock

6.72 USD
0 (0%)
Last: 12/31/2025, 8:07:43 PM
6.72 USD
0 (0%)
After Hours: 12/31/2025, 8:07:43 PM
Fundamental Rating

3

INGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. The financial health of INGN is average, but there are quite some concerns on its profitability. INGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year INGN has reported negative net income.
In the past year INGN has reported a negative cash flow from operations.
INGN had negative earnings in each of the past 5 years.
In multiple years INGN reported negative operating cash flow during the last 5 years.
INGN Yearly Net Income VS EBIT VS OCF VS FCFINGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

INGN's Return On Assets of -8.27% is fine compared to the rest of the industry. INGN outperforms 64.52% of its industry peers.
The Return On Equity of INGN (-12.87%) is better than 66.13% of its industry peers.
Industry RankSector Rank
ROA -8.27%
ROE -12.87%
ROIC N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
INGN Yearly ROA, ROE, ROICINGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a Gross Margin value of 44.76%, INGN is not doing good in the industry: 62.37% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of INGN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for INGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
INGN Yearly Profit, Operating, Gross MarginsINGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

INGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INGN has more shares outstanding
INGN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for INGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INGN Yearly Shares OutstandingINGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INGN Yearly Total Debt VS Total AssetsINGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

INGN has an Altman-Z score of 1.59. This is a bad value and indicates that INGN is not financially healthy and even has some risk of bankruptcy.
INGN has a Altman-Z score (1.59) which is comparable to the rest of the industry.
INGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACCN/A
WACC8.78%
INGN Yearly LT Debt VS Equity VS FCFINGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

INGN has a Current Ratio of 3.14. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 3.14, INGN perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
INGN has a Quick Ratio of 2.75. This indicates that INGN is financially healthy and has no problem in meeting its short term obligations.
INGN's Quick ratio of 2.75 is fine compared to the rest of the industry. INGN outperforms 63.44% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 2.75
INGN Yearly Current Assets VS Current LiabilitesINGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.22% over the past year.
Looking at the last year, INGN shows a small growth in Revenue. The Revenue has grown by 4.68% in the last year.
INGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.49% yearly.
EPS 1Y (TTM)58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%4%

3.2 Future

INGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.49% yearly.
INGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.67% yearly.
EPS Next Y36.25%
EPS Next 2Y23.43%
EPS Next 3Y16.49%
EPS Next 5YN/A
Revenue Next Year7.88%
Revenue Next 2Y8.11%
Revenue Next 3Y6.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INGN Yearly Revenue VS EstimatesINGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
INGN Yearly EPS VS EstimatesINGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INGN Price Earnings VS Forward Price EarningsINGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INGN Per share dataINGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as INGN's earnings are expected to grow with 16.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.43%
EPS Next 3Y16.49%

More info and screens

0

5. Dividend

5.1 Amount

INGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

INOGEN INC

NASDAQ:INGN (12/31/2025, 8:07:43 PM)

After market: 6.72 0 (0%)

6.72

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners72.55%
Inst Owner Change-1.48%
Ins Owners2.06%
Ins Owner Change1.51%
Market Cap182.45M
Revenue(TTM)347.03M
Net Income(TTM)-25.38M
Analysts82.5
Price Target13.26 (97.32%)
Short Float %3.21%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.46%
Min EPS beat(2)42.07%
Max EPS beat(2)44.85%
EPS beat(4)4
Avg EPS beat(4)42.91%
Min EPS beat(4)33.97%
Max EPS beat(4)50.73%
EPS beat(8)7
Avg EPS beat(8)27.49%
EPS beat(12)9
Avg EPS beat(12)24.7%
EPS beat(16)11
Avg EPS beat(16)18.95%
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)-0.15%
Revenue beat(4)2
Avg Revenue beat(4)1.43%
Min Revenue beat(4)-1.76%
Max Revenue beat(4)6.23%
Revenue beat(8)5
Avg Revenue beat(8)1.9%
Revenue beat(12)5
Avg Revenue beat(12)-0.4%
Revenue beat(16)8
Avg Revenue beat(16)0.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.17%
EPS NY rev (1m)1.55%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS12.78
BVpS7.26
TBVpS5.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.27%
ROE -12.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.76%
FCFM N/A
ROA(3y)-21.41%
ROA(5y)-13.35%
ROE(3y)-32.95%
ROE(5y)-20.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-0.6%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.85%
Cap/Sales 3.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.14
Quick Ratio 2.75
Altman-Z 1.59
F-Score6
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)106.82%
Cap/Depr(5y)105.29%
Cap/Sales(3y)6.42%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48%
EPS Next Y36.25%
EPS Next 2Y23.43%
EPS Next 3Y16.49%
EPS Next 5YN/A
Revenue 1Y (TTM)4.68%
Revenue growth 3Y-2.12%
Revenue growth 5Y-1.49%
Sales Q2Q%4%
Revenue Next Year7.88%
Revenue Next 2Y8.11%
Revenue Next 3Y6.67%
Revenue Next 5YN/A
EBIT growth 1Y48.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year104.09%
EBIT Next 3Y30.49%
EBIT Next 5YN/A
FCF growth 1Y43.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.64%
OCF growth 3Y-36.98%
OCF growth 5Y-31.97%

INOGEN INC / INGN FAQ

What is the fundamental rating for INGN stock?

ChartMill assigns a fundamental rating of 3 / 10 to INGN.


What is the valuation status for INGN stock?

ChartMill assigns a valuation rating of 0 / 10 to INOGEN INC (INGN). This can be considered as Overvalued.


How profitable is INOGEN INC (INGN) stock?

INOGEN INC (INGN) has a profitability rating of 2 / 10.


How financially healthy is INOGEN INC?

The financial health rating of INOGEN INC (INGN) is 6 / 10.